Table 2.
Demographic characteristics and relating factors according to the organisms.
| VRE | P-value | CRE | P-value | |||
| Decolonization Organism | Success in VRE (n = 11) | Fail in VRE (n = 8) | Success in CRE (n = 9) | Fail in CRE (n = 4) | ||
| Age∗ | 67.75 ± 12.30 | 79.17 ± 3.97 | .037 | 62.71 ± 19.09 | 77.33 ± 2.31 | .022 |
| Sex (male/female) | 5/3 | 3/3 | 1.000 | 2/5 | 0/3 | .467 |
| BMI | 20.28 ± 3.47 | 16.78 ± 0.50 | .061 | 18.70 ± 1.47 | 16.96 ± 1.10 | .171 |
| Disease | Stroke (n = 6) | Stroke (n = 4) | Stroke (n = 5) | Stroke (n = 2) | ||
| Parkinsonism (n = 1) | TBI (n = 1) | Brain abscess (n = 2) | Parkinson (n = 1) | |||
| TBI (n = 1) | Esophageal cancer (n = 1) | AKA (n = 1) | Hip fracture (n = 1) | |||
| Hypoxic brain damage (n = 1) | TB spondylitis (n = 1) | C-myelopathy (n = 1) | ||||
| Cardiac op (n = 1) | Compression fracture (n = 1) | |||||
| Esophageal rupture (n = 1) | ||||||
| Detected organ (stool/urine/wound) | 8/3/0 | 6/2/0 | .361 | 6/3/0 | 1/2/1 | .571 |
| Admission to VRE /CRE detect (weeks) | 13.50 ± 16.03 | 18.77 ± 19.25 | .435 | 13.14 ± 7.73 | 13.33 ± 6.11 | .908 |
| VRE/CRE isolation period (weeks) | 17.43 ± 14.61 | 26.82 ± 10.76 | .174 | 12.57 ± 4.65 | 19.40 ± 9.64 | .302 |
| VRE/CRE isolation period without protocol trial. (weeks)∗ | 6.13 ± 6.23 | 16.93 ± 8.01 | .024 | 4.43 ± 2.51 | 8.40 ± 2.65 | .007 |
| Period of decolonization protocol trial (weeks) | 10.50 ± 8.85 | 12.33 ± 6.09 | .560 | 8.14 ± 4.67 | 12.67 ± 10.79 | .643 |
| K-MBI∗ | 61.25 ± 25.07 | 24.07 ± 12.39 | .008 | 51.14 ± 26.35 | 34.33 ± 12.90 | .030 |
| FAC∗ | 3.38 ± 1.30 | 1.33 ± 0.52 | .006 | 2.14 ± 1.21 | 0.67 ± 0.58 | .007 |
| Grip power∗ | 19.91 ± 8.17 | 9.97 ± 3.75 | .014 | 18.80 ± 9.65 | 12.47 ± 1.65 | .041 |
| Feeding method (non-oral/LD/RD) | 2/4/2 | 3/2/1 | .801 | 0/3/4 | 1/2/0 | .250 |
| Bladder function (Foley/diapers/toileting) | 2/3/3 | 4/2/0 | .199 | 0/5/2 | 3/0/0 | .008 |